Stockreport

Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference [Yahoo! Finance]

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF of $805M–$825M (about 4% YoY ) and adjusted EBITDA of $455M–$475M (~ 1% YoY ), with ADHD franchise Jornay PM expected to generate $190M–$200M (~31% YoY at midpoint). T [Read more]